The mononuclear phagocyte system contributes to fibrosis in post-transplant obliterans bronchiolitis.
Journal
The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
17
02
2020
accepted:
16
09
2020
pubmed:
10
10
2020
medline:
3
7
2021
entrez:
9
10
2020
Statut:
epublish
Résumé
Bronchiolitis obliterans syndrome (BOS) is a fibrotic disease that is heavily responsible for the high mortality rates after lung transplantation. Myofibroblasts are primary effectors of this fibrotic process, but their origin is still debated. The purpose of this work was to identify the precursors of mesenchymal cells responsible for post-transplant airway fibro-obliteration.Lineage-tracing tools were used to track or deplete potential sources of myofibroblasts in the heterotopic tracheal transplantation model. Allografts were analysed by histology, confocal microscopy, flow cytometry or single-cell transcriptomic analysis. BOS explants were evaluated by histology and confocal microscopy.Myofibroblasts in the allografts were recipient-derived. When recipient mice were treated with tacrolimus, we observed rare epithelial-to-mesenchymal transition phenomena and an overall increase in donor-derived myofibroblasts (p=0.0467), but the proportion of these cells remained low (7%). Haematopoietic cells, and specifically the mononuclear phagocyte system, gave rise to the majority of myofibroblasts found in occluded airways. Ablation of Cx3cR1
Identifiants
pubmed: 33033147
pii: 13993003.00344-2020
doi: 10.1183/13993003.00344-2020
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright ©ERS 2021.
Déclaration de conflit d'intérêts
Conflict of interest: M-P. Di Campli has nothing to disclose. Conflict of interest: A. Azouz has nothing to disclose. Conflict of interest: A. Assabban has nothing to disclose. Conflict of interest: J. Scaillet has nothing to disclose. Conflict of interest: M. Splittgerber has nothing to disclose. Conflict of interest: A. Van Keymeulen has nothing to disclose. Conflict of interest: F. Libert has nothing to disclose. Conflict of interest: M. Remmelink has nothing to disclose. Conflict of interest: A. Le Moine has nothing to disclose. Conflict of interest: P. Lemaitre has nothing to disclose. Conflict of interest: S. Goriely has nothing to disclose.